Read full paper at: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=52744#.VKIMVcCAM4 Author(s) Zivar Shirinpour * , Bahman Ghaderian * , Homeira Rashidi , Armaghan Moravej Aleali , Seyed Peyman Payami Affiliation(s) Health Research Institute, Diabetes Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran . ABSTRACT Introduction: Poly cystic ovary (PCO) is one of the most common endocrine disorders in women. All patients with PCO are at risk of insulin resistance, IFG and diabetes. Recently, bromocriptine is used in treatment of diabetes mellitus type II to improve insulin resistance. Objective: The aim of this study is the evaluation of bromocriptine on in...
Scientific Research Publishing